The economic crisis in Lebanon, compounded by the destruction of the Beirut Port and the COVID-19 pandemic, has severely impacted the health sector, particularly the pharmaceutical and medical supply industry. This has underscored the need for Lebanon to establish a stable and secure source of prescription drug production. The study presents two potential solutions: (1) revising the subsidy system to support local pharmaceutical production, and (2) advocating for the prescription and use of generic drugs. Investing in local drug production can foster trust in the quality of domestically produced medicines. This can be supplemented by promoting the use of generic drugs, once a robust system for local drug production is in place. The study emphasizes the importance of both immediate measures to address the current crisis and long-term strategies to ensure sustainable pharmaceutical supply.
You can submit a specific query to QUAMED experts by clicking on the button below. We will send relevant answers directly to your mailbox.
Submit Query
The information provided on this Web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.
ISO 9001:2015 - FS766975
© 2024 - QUAMED
Content of this site is licensed under a Creative Commons License- BY Attribution